CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
Clinical trials for CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Last-Resort drug access opens for CML patients
Disease control AVAILABLEThis program provides access to asciminib (ABL001) for people with chronic-phase chronic myeloid leukemia who have no other treatment options and cannot join a clinical trial. Doctors can request the drug for individual patients who may benefit. The goal is to offer a potential t…
Matched conditions: CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New hope for leukemia patients: asciminib study launches in china
Disease control Recruiting nowThis study looks at how well and how safely the drug asciminib works for people newly diagnosed with a type of leukemia called chronic myeloid leukemia (CML). About 200 adults in China will take the drug and be followed for at least 12 months. The main goal is to see how many ach…
Matched conditions: CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:11 UTC